Shares of Solventum Corp. SOLV rose 1.33% to $75.15 Monday, on what proved to be an all-around favorable trading session for ...

Solventum presently has a consensus price target of $79.86, suggesting a potential upside of 7.46%. As a group, “Surgical & medical instruments” companies have a potential upside of 31.83%.

Shares of Solventum Corp. SOLV slipped 2.31% to $72.30 Thursday, on what proved to be an all-around rough trading session for ...

Raymond James Financial Inc. bought a new position in shares of Solventum Co. (NYSE:SOLV – Free Report) in the 4th quarter, ...

Shares of Solventum rose Tuesday after the company agreed to sell its filtration and purification business to medical device maker Thermo Fisher Scientific for $4.1 billion. Solventum Chief ...

Solventum Corp., 3M’s medtech spinoff, has sold its purification and filtration business to Massachussetts-based Thermo Fisher Scientific for approximately $4.1 billion. Solventum Corp. (NYSE ...

ST. PAUL, Minn., March 12, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV), formerly 3M Health Care, today announced the launch of the Attest™ eBowie-Dick Test System (eBowie-Dick System), an ...

Diversified healthcare company Solventum (NYSE:SOLV) reported fourth-quarter 2024 earnings on Thursday, Feb. 27, that topped analysts' consensus estimates. Adjusted EPS for the quarter came in at ...

Solventum (SOLV) announced it has entered into a definitive agreement to sell its Purification & Filtration business to Thermo Fisher Scientific (TMO) for $4.1B. Solventum expects the transaction ...

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal ...

In the final days of November, I was getting slightly concerned about a long position in Solventum Corporation (NYSE:SOLV) after shares had enjoyed a partial re-rating. By now, the healthcare spin ...

Trian Fund Management, which beneficially owns about 5% of Solventum (SOLV) and is the company’s largest active shareholder, commented on Solventum’s recently announced sale of its ...